The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
Abstract
The Vaccine Adverse Event Reporting System (VAERS) is administered by the Food and Drug Administration and CDC and is a key component of postlicensure vaccine safety surveillance. Its primary function is to detect early warning signals and generate hypotheses about possible new vaccine adverse events or changes in frequency of known ones. VAERS is a passive surveillance system that relies on physicians and others to voluntarily submit reports of illness after vaccination. Manufacturers are required to report all adverse events of which they become aware. There are a number of well-described limitations of such reporting systems. These include, for example, variability in report quality, biased reporting, underreporting and the inability to determine whether a vaccine caused the adverse event in any individual report. Strengths of VAERS are that it is national in scope and timely. The information in VAERS reports is not necessarily complete nor is it verified systematically. Reports are classified as serious or nonserious based on regulatory criteria. Reports are coded by VAERS in a uniform way with a limited number of terms using a terminology called COSTART. Coding is useful for search purposes but is necessarily imprecise. VAERS is useful in detecting adverse events related to vaccines and most recently was used for enhanced reporting of adverse events in the national smallpox immunization campaign. VAERS data have always been publicly available. However, it is essential for users of VAERS data to be fully aware of the strengths and weaknesses of the system. VAERS data contain strong biases. Incidence rates and relative risks of specific adverse events cannot be calculated. Statistical significance tests and confidence intervals should be used with great caution and not routinely. Signals detected in VAERS should be subjected to further clinical and descriptive epidemiologic analysis. Confirmation in a controlled study is usually required. An understanding of the system's defined objectives and inherent drawbacks is vital to the effective use of VAERS data in vaccine safety investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
A Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 505
Self-citationThe Vaccine Adverse Event Reporting System (VAERS)
CHEN, R., RASTOGI, S., MULLEN, J., HAYES, S., COCHI, S., DONLON, J., & WASSILAK, S. (1994) · Vaccine · doi:10.1016/0264-410x(94)90315-8 · Cited by 498
Self-citationThe Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Chen, R. T., Glasser, J. W., Rhodes, P. H., Davis, R. L., Barlow, W. E., Thompson, R. S., Mullooly, J. P., Black, S. B., Shinefield, H. R., Vadheim, C. M., et al. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.765 · Cited by 346
Self-citationVaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
DeStefano, F. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.504 · Cited by 256
Self-citationPostlicensure Safety Surveillance for Varicella Vaccine
Wise, R. P. (2000) · JAMA · doi:10.1001/jama.284.10.1271 · Cited by 213
The reporting sensitivities of two passive surveillance systems for vaccine adverse events.
Rosenthal, S., & Chen, R. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.12.1706 · Cited by 201
Self-citation
Cited by
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & DeStefano, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 608
Self-citationTaylor, L. E., Swerdfeger, A. L., & Eslick, G. D. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.085 · Cited by 583
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
Slade, B. A. (2009) · JAMA · doi:10.1001/jama.2009.1201 · Cited by 470
The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J., Gee, J., Lewis, E., Fowler, G., Benson, P., Lieu, T., Naleway, A., Klein, N. P., Baxter, R., Belongia, E., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-1722h · Cited by 349
Adverse event reports following yellow fever vaccination
Lindsey, N. P., Schroeder, B. A., Miller, E. R., Braun, M. M., Hinckley, A. F., Marano, N., Slade, B. A., Barnett, E. D., Brunette, G. W., Horan, K., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.009 · Cited by 283
Self-citation
Metadata
- Authors
- VARRICCHIO, F., ISKANDER, J., DESTEFANO, F., BALL, R., PLESS, R., BRAUN, M. M., & CHEN, R. T.
- Venue
- The Pediatric Infectious Disease Journal
- Published
- 2004-04
- Volume
- 23
- Issue
- 4
- Pages
- 287-294
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W1983077458
- Cited by
- 380
- References
- 31
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. https://app.cochat.ai/papers/10.1097/00006454-200404000-00002
- The paper
- VARRICCHIO, F., ISKANDER, J., DESTEFANO, F., BALL, R., PLESS, R., BRAUN, M. M., & CHEN, R. T. (2004). Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. The Pediatric Infectious Disease Journal. https://doi.org/10.1097/00006454-200404000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.